Organ Preservation Market
Market Insights on Organ Preservation covering sales outlook, demand forecast & up-to-date key trends
Organ Preservation Market by Solution (University of Wisconsin Solution, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermia Machine Perfusion, and Normothermic Machine Perfusion), Organ Type (Kidney, Liver, Lung, Heart, Pancreas), End User (Organ Transplant Centres, Hospitals, Speciality Clinics) & Region - Forecast 2022 - 2032
Organ Preservation Market (2022-2032)
[323 Pages Report] Global organ preservation market value is estimated to reach US$ 455 Million by 2032, with a compound annual growth rate of 6.4%.
- Growing demand for organ transplants and organ failures is expected to drive the market
- A growing number of diseases is expected to propel market growth for the organ preservation market
- Investments in healthcare will promote organ preservation growth.
- Kidney transplant rates will rise due to increased cases of kidney failure and chronic kidney disease.
The process of preserving healthy organs from a donor so that they can be transplanted into the body of a recipient is called organ preservation. Static cold storage (SCS) aids in maintaining normal organ function after transplantation by preventing harmful metabolites from degrading healthy tissue.
Those suffering from terminal diseases are the most likely to benefit from organ transplantation. Preservation solutions and techniques are essential to preserving organ quality and preventing transplant-associated death and morbidity. In most cases, static cold storage (SCS) is considered to be the most efficient and effective method of preserving and transporting organs due to its simplicity and effectiveness.
Over the past few decades, solid organ transplants have been one of the most significant medical advancements. A wide variety of methods for preserving organs have been applied during cold storage to reduce ischemic and hypoxic injury and increase graft survival.
Since the advent of clinical organ transplants 50 years ago, patient and graft survival rates have surpassed 90% per year, resulting in organ transplantation becoming the treatment of choice for end-stage organ disease patients.
|
Attributes |
Details |
|
Organ Preservation Market CAGR (2022-2032) |
6.4% |
|
Organ Preservation Market (2026) |
US$ 317 Mn |
|
Organ Preservation Market Attraction |
Rising proportion of geriatric population in North America and European countries will be the major driver for the growth of global organ preservation market during the forecasted years. |
Let us know your requirement to get
100% FREE customization
Growth Prospects of Organ Preservation in the Asia Pacific Region
With the largest population seeking better treatments, including organ transplantation preservation, the Asia Pacific region is expected to be the fastest-growing region as a whole in the industry. Asian countries are seeing an increase in awareness about organ donation, which has led to a rise in the market for organ preservation solutions.
Developing nations such as India and China are experiencing an increase in the eye, cardiac, and kidney diseases. Technology advancement and emerging markets will offer profitable opportunities for the market. The government has also taken several initiatives to promote organ donation as part of its efforts to further expand the market growth. For instance,
Organ donation and transplantation are promoted by the Indian government through its National Organ Transplant Programme (NOTP). Several regional and state organ and tissue transplant organizations have been established under this initiative: one at the highest level in New Delhi, five at the regional level, and sixteen at the state level.
Additionally, the National Organ Transplant Programme provides financial assistance to States for the establishment of Biomaterial Centers. Various IEC activities are being organized to raise public awareness and impart training to physicians and transplant coordinators to facilitate the acceptance of transplants.
Future Research Trends in Organ Preservation Markets
With targeted radiotherapy and chemotherapy, medical professionals aim to preserve a surgically removed organ by preventing the particular cell from multiplying as a result of targeting radiotherapy and chemotherapy. As part of UICC's Access to Oncology Medicines (ATOM) initiative, multiple stakeholders were invited to the table to find ways of making cancer medicines more accessible and affordable especially in India.
An exciting development in health care has been the development of xenotransplantation - the ability to use a genetically modified organ from an animal to be used in humans after genetic modification. As gene editing techniques are developed and new knowledge is gained about the immunology of animals and its differences from the immune system of humans, it will probably continue to be a field that sees many advancements in the near future.
“The geriatric population count is increasing day by day, leading to increased incidents of multi-organ failures and organ transplant surgeries worldwide. The requirement of efficient management of organ transfer from donors is driving the organ preservation market. ”
In 2019, the Health Resources and Services Administration reported about the rise in death cases due to multiple organ failures in the US. The major treatment for such types of patients is organ replacement facilitated by human organ transplantation surgeries.
The organs obtained from donors require the appropriate handling and care achieved through the proper organ storage in cryogenic systems. The companies providing organic preservation solutions to hold and carry the organs from donors to patients have experienced exponential growth these days.
Organ procurement and transplant network have expanded many folds making it easier for patients suffering from organ disorders. Organ preservation chemicals used for the storage of such organs obtained from companies dealing in the medical sector have benefitted immensely in recent years.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat is the Covid-19 Impact on the Global Organ Preservation Market?
Healthcare and medical facilities in all countries were diverted towards the control of the corona infection cases. The other medical services were abruptly halted, negatively impacting the organ preservation and transplantation market.
All the patients requiring the replacement of organs had to undergo rigorous Covid-19 testing and confirmation before getting admitted to any healthcare facilities. Most of the skilled surgeons and healthcare professionals were also engaged in taking care of patients admitted with Covid-19 symptoms.
The problem in obtaining raw materials for the production of organ preservation solutions in the manufacturing units had some serious impact on the supply of preserved organs over long distances.
Restrictions on transportation and logistics were another major problem hampering the transport of human organs preserved for donation. In post-pandemic years demand for organ preservation and transplantation services increased due to serious effects of the coronavirus on the internal organs of the body.
What are the Dynamics in the Organ Preservation Market?
“Diabetes and Chronic diseases have increased in frequency in the recent past resulting in severe medical conditions for multiple organ failures. Cardiovascular disorders and obesity have escalated the condition of patients to undertake replacement of organs providing a huge impetus for the growth of organ preservation market across the globe.”
Solid-Organ transplant procedures have become more successful and safer in the 21st century owing to considerable advancement in surgical procedures and knowledge about the function of different organs.
But the healthcare sector is still struggling to meet the demands for organ transplantation due to the unavailability of sufficient organ donors or limited supply of organ preservation fluids required to store and transport the organs already donated.
What are the Recent Developments providing Better Opportunities for the Growth of Organ Preservation Market?
Over the past years, there have been some major advancements in medical science, particularly in the field of organ preservation techniques and transplantation procedures, creating a huge demand for organ transplants in the global market. Coupled with the rising burden of diabetes patients, the demand for static cold storage organ preservation requirements during these years.
Encouragement for organ donations by various national and international NGOs has spurred the demand for organ preservation chemicals in the lesser-known regions of the world.
Improving health infrastructure across all countries has resulted in increased cases of patient termination in healthcare and medical facilities. The growing supply of organ preservation solutions in such major institutions has made it easier for the collection and preservation of human organs to be utilized by the organ preservation market.
What are Some of the Major Challenges faced by the Global Organ Preservation Market Players in Different Regions?
The development of cryogenic facilities for the maintenance of organ preservation fluid quality during transportation is a major challenge for the global organ preservation market, particularly in developing countries of the Asia Pacific and the Middle East and Africa (MEA).
The cost incurred during organ transplant surgeries and higher expenditure on inpatient care provided by healthcare facilities has remained the major constraint for the growth of the organ preservation and transplantation market. Patients in low-income countries require low-budget healthcare facilities to contribute more to the organ preservation market.
What are the Limitations in the Adoption of Organ Preservation Techniques in Recent Period?
Availability of skilled personnel or surgery doctors at the healthcare centers is pride predicted to be the major challenge for the growth of the organ preservation and transplantation market during the forecast period at a higher scale.
Availability of suitable donors can be another major hindrance in the development of organ preservation techniques reducing the investment in research and advancement of organ preservation procedures by the government institutions and private firms.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Comparative View of Adjacent Organ Preservation Market
Organ Preservation Market:
|
Attributes |
Organ Preservation Market |
|
CAGR (2022 - 2032) |
6.4% |
|
Market Value (2026) |
US$ 317 Mn |
|
Growth Factor |
Multi-organ failure is becoming more common, and the geriatric population is expanding which is driving the market. |
|
Opportunity |
Governments all around the world are working to improve their healthcare infrastructures in order to deliver better services. |
|
Key Trends |
The rising number of organ transplants and increased attempts to encourage organ donation are driving market expansion in APAC. |
Cardiac Monitoring & Cardiac Rhythm Management Devices Market:
|
Attributes |
Cardiac Monitoring & Cardiac Rhythm Management Devices Market |
|
CAGR (2022 - 2032) |
4% |
|
Market Value (2026) |
US$ 27.9 Bn |
|
Growth Factor |
Increase in the incidence of diseases such as hypertension, diabetes, dyslipidemia, and obesity as a result of lifestyle changes, all of which contribute to the rising prevalence of Cardiovascular Diseases around the world. |
|
Opportunity |
Measures to reduce infections caused due to CIEDs present a growing opportunity for the market. |
|
Key Trends |
Launch of innovative products and technological advancements is propelling the market forward. |
Bio preservation Market
|
Attributes |
Bio preservation Market |
|
CAGR (2022 - 2032) |
9.1% |
|
Market Value (2026) |
US$ 5.3 Bn |
|
Growth Factor |
Biobanking breakthroughs and increased R&D investments. |
|
Opportunity |
Emerging economies will provide considerable growth prospects for market participants. |
|
Key Trends |
The industry is likely to grow as investments in regenerative medicine research increase. The expensive cost of bio preservation equipment, on the other hand, will limit market expansion. |
Organ replacement or transplantation is a complex process requiring a wide range of resources for successful completion. Every step in organ preservation and transplantation requires constant monitoring by skilled personnel and is cost-intensive.
Services provided by the healthcare establishments during the organ preservation time is also an expensive method incurred in the bills of patients. However, the bettering economic conditions and support from the government have set the stage for organ replacement surgeries as a more acceptable choice than before.
Moreover, the ever-advancing technological progress in the field of organ storage has lowered the cost of organ transplantation surgeries than before. In the coming years, the cost is expected to fall down owing to the resources invested by market players for carrying out research and development activities in the direction of new methods for organ preservation for transplantation.
How is the Growth Outlook for the Organ Preservation Market on the basis of Different Segments?
The most adopted technique is the static cold storage organ preservation method, commonly referred to as the gold standard technique of Organ preservation. This technique is very convenient to reduce metabolic activities and increase the self-life of the organs. This technique is popular for lung, heart, pancreas and kidney preservation.
Hypothermia Machine Perfusion and Normothermic Machine Perfusion are some of the other techniques that need some research and technological advancements to compete with the static cold storage technique segment.
Which are the Major Organs Constituting the Different Segments of Global Organ Preservation Market?
By the previous market analysis report, kidney preservation was the segment holding the largest share of the global organ preservation market. The escalating cases of ESRD with kidney transplantation has emerged as the major driver for this segment of the market and is predicted to be leading in the forthcoming years.
The other segment based on organ type having the highest potential of growth is liver preservation during the forecast period of 2022 to 2032. Lung, heart and pancreas preservation are the other segments contributing to the growing trend of organ preservation.
Who are the Prominent End Users of the Global Organ Preservation Market?
By 2021, organ transplant centers were the dominating end users of the organ preservation market providing kidney preservation and liver preservation in different regions of the world. The better healthcare facilities and the increasing success rate has made it a popular choice for patients seeking organ replacement around the world. This segment is expected to remain at the forefront for organ preservation and transplantation during the forecast years.
Hospitals and other end users will also contribute significantly to the global organ preservation market, as per the report of the market analysis.
What is the Prospect of Growth for the Global Organ Preservation Market in Different Geographical Regions?
North America, comprising a higher proportion of the elder population and advanced Healthcare facilities, is poised to remain the most attractive region for organ storage and transplantation services.
In addition to the rising demand for technologically advanced treatment methods, government support and reimbursements have fuelled the market for preserved human organs in recent times.
As per the report provided by the American Heart Association and National Chronic kidney Disease Report, 31% of the total deaths in the US occurred due to cardiovascular disorders in 2014 and in 2017, 15% of US adults were subject to chronic kidney diseases.
Due to rising cases of alcoholic fatty liver diseases, Liver failures have positioned the Europe region as the second-largest market for organ preservation and transplantation, following North America. The healthcare expenditure in European countries has further fuelled the market for lever preservation for transplant facilities.
The prevalence of other serious diseases related to cardiovascular and renal will further supplement the demand for organ transplantation surgeries in this region.
Asia Pacific region is predicted to be the fastest-growing region for having the largest population count seeking better treatment methods, including organ transplantation preservation
services. The rising awareness about organ donations has boosted the organ preservation solution market in Asian countries.
Lack of awareness and affordability constraints for organ preservation techniques could render the Middle East and African countries the least attractive region for the global organ preservation market in coming years.
How is the Competitive Landscape for different Key Players of the Global Organ Preservation Market?
The key players in the organ preservation driving the global market are XVIVO Perfusion AB, Dr Franz Kohler Chemie GmbH, Essential Pharmaceuticals LLC, Trans Medics, Organ Ox Limited, Shanghai Genext Medical Technology, Bridge to Life Limited, Waters Medical Systems, Preservation Solutions, Carnamedica, and Transplant Biomedicals.
All the prominent players dealing in organ preservation have continually adopted the advancing technologies and have changed the course of organ preservation from the past to the future to provide the best service for the patients in need.
In recent years they have been focusing on mergers and collaboration to expand the customer base in traditionally less popular regions.
Some of the Recent Developments in Organ Preservation Market:
- Paragonix Technologies of the US expanded its product offerings in the United States and Europe to strengthen its geographic presence by launching a LIVERgaurd Donor Liver Preservation System in 2021.
- To gain access to transplantation networks in Latin America in 2021, XVIVO perfusion of Sweden partnered with Contatti Medical of Brazil.
- Institute Georges Lopez (IgI) of France set up a manufacturing facility in Tamil Nadu, India, in 2021 for expanding its business in medical devices and organ preservation solutions required for flushing and preservation of organs.
- OCS Heart System prepared by Transmedics company of USA received premedical approval from Food and Drug Administration (FDA) in 2021 for use with organs obtained from donors after brain death (DBD).
- For distribution and marketing of custodial HTK solutions in the Chinese and Asia Pacific market Dr. Franz Köhler Chemie GmbH, Melchers Group and CICEL of Germany started a joint venture in 2020 by the name of Köhler Pharmaceuticals at Beijing.
Key Segments
By Solution:
- University of Wisconsin Solution (UW Solution)
- Custodial HTK
- Perfadex
- Other Solutions
By Technique:
- Static Cold Storage
- Hypothermia Machine Perfusion
- Normothermic Machine Perfusion
By Organ Type:
- Kidney
- Liver
- Long
- Heart
- Pancreas
By End User:
- Organ Transplant Centres
- Hospitals
- Speciality Clinics
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa (MEA)
Frequently Asked Questions
The global organ preservation market is predicted to register a CAGR of 6.4% during the forecast period.
The global organ preservation market was valued at US$ 230 Mn in 2021.
The global organ preservation market is predicted to become a US$ 317 Mn market by the year 2026.
The total market value of organ preservation market is estimated to reach a value of about US$ 455 Mn by the end of 2032.
North America is the dominant region that captured major share of the global organ transplant preservation market and is predicted to remain in the leading position for some more years ahead.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Market
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Market, by Key Countries
4.2. MarketOpportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Market Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. MarketOpportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Solution
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Solution , 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Solution , 2022-2032
8.3.1. University of Wisconsin Solution (UW Solution)
8.3.2. Custodial HTK
8.3.3. Perfadex
8.3.4. Other Solutions
8.4. Market Attractiveness Analysis By Solution
9. Global MarketAnalysis 2015-2021 and Forecast 2022-2032, By Technique
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Technique , 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique , 2022-2032
9.3.1. Static Cold Storage
9.3.2. Hypothermic Machine Perfusion
9.3.3. Normothermic Machine Perfusion
9.4. Market Attractiveness Analysis By Technique
10. Global MarketAnalysis 2015-2021 and Forecast 2022-2032, By Organ Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Organ Type , 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Organ Type , 2022-2032
10.3.1. Kidney
10.3.2. Liver
10.3.3. Lung
10.3.4. Heart
10.3.5. Pancreas
10.4. Market Attractiveness Analysis By Organ Type
11. Global MarketAnalysis 2015-2021 and Forecast 2022-2032, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User , 2015-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2032
11.3.1. Organ Transplant Centers
11.3.2. Hospitals
11.3.3. Specialty Clinics
11.4. Market Attractiveness Analysis By End User
12. Global MarketAnalysis 2015-2021 and Forecast 2022-2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America MarketAnalysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Solution
13.4.3. By Technique
13.4.4. By End User
13.4.5. By Organ Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Solution
13.5.3. By Technique
13.5.4. By End User
13.5.5. By Organ Type
14. Latin America MarketAnalysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Solution
14.4.3. By Technique
14.4.4. By End User
14.4.5. By Organ Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Solution
14.5.3. By Technique
14.5.4. By End User
14.5.5. By Organ Type
15. Europe MarketAnalysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Solution
15.4.3. By Technique
15.4.4. By End User
15.4.5. By Organ Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Solution
15.5.3. By Technique
15.5.4. By End User
15.5.5. By Organ Type
16. Asia Pacific MarketAnalysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Solution
16.4.3. By Technique
16.4.4. By End User
16.4.5. By Organ Type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Solution
16.5.3. By Technique
16.5.4. By End User
16.5.5. By Organ Type
17. Middle East and Africa MarketAnalysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Solution
17.4.3. By Technique
17.4.4. By End User
17.4.5. By Organ Type
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Solution
17.5.3. By Technique
17.5.4. By End User
17.5.5. By Organ Type
18. Key Countries MarketAnalysis 2015-2021 and Forecast 2022-2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US MarketAnalysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.2.2.1. By Solution
18.2.2.2. By Technique
18.2.2.3. By End User
18.2.2.4. By Organ Type
18.3. Canada MarketAnalysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.3.2.1. By Solution
18.3.2.2. By Technique
18.3.2.3. By End User
18.3.2.4. By Organ Type
18.4. Mexico MarketAnalysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.4.2.1. By Solution
18.4.2.2. By Technique
18.4.2.3. By End User
18.4.2.4. By Organ Type
18.5. Brazil MarketAnalysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.5.2.1. By Solution
18.5.2.2. By Technique
18.5.2.3. By End User
18.5.2.4. By Organ Type
18.6. Germany MarketAnalysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.6.2.1. By Solution
18.6.2.2. By Technique
18.6.2.3. By End User
18.6.2.4. By Organ Type
18.7. France MarketAnalysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.7.2.1. By Solution
18.7.2.2. By Technique
18.7.2.3. By End User
18.7.2.4. By Organ Type
18.8. Italy MarketAnalysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.8.2.1. By Solution
18.8.2.2. By Technique
18.8.2.3. By End User
18.8.2.4. By Organ Type
18.9. BENELUX MarketAnalysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.9.2.1. By Solution
18.9.2.2. By Technique
18.9.2.3. By End User
18.9.2.4. By Organ Type
18.10. UK MarketAnalysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.10.2.1. By Solution
18.10.2.2. By Technique
18.10.2.3. By End User
18.10.2.4. By Organ Type
18.11. Nordic Countries MarketAnalysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.11.2.1. By Solution
18.11.2.2. By Technique
18.11.2.3. By End User
18.11.2.4. By Organ Type
18.12. China MarketAnalysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.12.2.1. By Solution
18.12.2.2. By Technique
18.12.2.3. By End User
18.12.2.4. By Organ Type
18.13. Japan MarketAnalysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.13.2.1. By Solution
18.13.2.2. By Technique
18.13.2.3. By End User
18.13.2.4. By Organ Type
18.14. South Korea MarketAnalysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.14.2.1. By Solution
18.14.2.2. By Technique
18.14.2.3. By End User
18.14.2.4. By Organ Type
18.15. GCC Countries MarketAnalysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.15.2.1. By Solution
18.15.2.2. By Technique
18.15.2.3. By End User
18.15.2.4. By Organ Type
18.16. South Africa MarketAnalysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.16.2.1. By Solution
18.16.2.2. By Technique
18.16.2.3. By End User
18.16.2.4. By Organ Type
18.17. Turkey MarketAnalysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.17.2.1. By Solution
18.17.2.2. By Technique
18.17.2.3. By End User
18.17.2.4. By Organ Type
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Paragonix Technologies
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. XVIVO Perfusion AB
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. Dr. Franz Köhler Chemie GmbH
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Essential Pharmaceuticals LLC
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. TransMedics
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. OrganOx Limited
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. Shanghai Genext Medical Technology
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. Bridge to Life Limited
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. Waters Medical Systems
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. Preservation Solutions
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview
20.3.11. Carnamedica
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Sales Footprint
20.3.11.4. Strategy Overview
20.3.12. Transplant Biomedicals
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Sales Footprint
20.3.12.4. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn),By Solution , 2015 – 2021
Table 2: Global Market Value (US$ Mn),By Solution , 2022 – 2032
Table 3: Global Market Value (US$ Mn), By Technique , 2015 – 2021
Table 4: Global Market Value (US$ Mn), By Technique , 2022 – 2032
Table 5: Global Market Value (US$ Mn), By Organ Type , 2015 – 2021
Table 6: Global Market Value (US$ Mn), By Organ Type , 2022 – 2032
Table 7: Global Market Value (US$ Mn), By End User , 2015 – 2021
Table 8: Global Market Value (US$ Mn), By End User , 2022 – 2032
Table 9: Global Market , By Region, 2015 – 2021
Table 10: Global Market , By Region, 2022 – 2032
Table 11: North America Market Value (US$ Mn),By Solution , 2015 – 2021
Table 12: North America Market Value (US$ Mn),By Solution , 2022 – 2032
Table 13: North America Market Value (US$ Mn), By Technique , 2015 – 2021
Table 14: North America Market Value (US$ Mn), By Technique , 2022 – 2032
Table 15: North America Market Value (US$ Mn), By Organ Type , 2015 – 2021
Table 16: North America Market Value (US$ Mn), By Organ Type , 2022 – 2032
Table 17: North America Market Value (US$ Mn), By End User , 2015 – 2021
Table 18: North America Market Value (US$ Mn), By End User , 2022 – 2032
Table 19: North America Market , By Country, 2015 – 2021
Table 20: North America Market , By Country, 2022 – 2032
Table 21: Latin America Market Value (US$ Mn),By Solution , 2015 – 2021
Table 22: Latin America Market Value (US$ Mn),By Solution , 2022 – 2032
Table 23: Latin America Market Value (US$ Mn), By Technique , 2015 – 2021
Table 24: Latin America Market Value (US$ Mn), By Technique , 2022 – 2032
Table 25: Latin America Market Value (US$ Mn), By Organ Type , 2015 – 2021
Table 26: Latin America Market Value (US$ Mn), By Organ Type , 2022 – 2032
Table 27: Latin America Market Value (US$ Mn), By End User , 2015 – 2021
Table 28: Latin America Market Value (US$ Mn), By End User , 2022 – 2032
Table 29: Latin America Market , By Country, 2015 – 2021
Table 30: Latin America Market , By Country, 2022 – 2032
Table 31: Europe Market Value (US$ Mn),By Solution , 2015 – 2021
Table 32: Europe Market Value (US$ Mn),By Solution , 2022 – 2032
Table 33: Europe Market Value (US$ Mn), By Technique , 2015 – 2021
Table 34: Europe Market Value (US$ Mn), By Technique , 2022 – 2032
Table 35: Europe Market Value (US$ Mn), By Organ Type , 2015 – 2021
Table 36: Europe Market Value (US$ Mn), By Organ Type , 2022 – 2032
Table 37: Europe Market Value (US$ Mn), By End User , 2015 – 2021
Table 38: Europe Market Value (US$ Mn), By End User , 2022 – 2032
Table 39: Europe Market , By Country, 2015 – 2021
Table 40: Europe Market , By Country, 2022 – 2032
Table 41: Asia Pacific Market Value (US$ Mn),By Solution , 2015 – 2021
Table 42: Asia Pacific Market Value (US$ Mn),By Solution , 2022 – 2032
Table 43: Asia Pacific Market Value (US$ Mn), By Technique , 2015 – 2021
Table 44: Asia Pacific Market Value (US$ Mn), By Technique , 2022 – 2032
Table 45: Asia Pacific Market Value (US$ Mn), By Organ Type , 2015 – 2021
Table 46: Asia Pacific Market Value (US$ Mn), By Organ Type , 2022 – 2032
Table 47: Asia Pacific Market Value (US$ Mn), By End User , 2015 – 2021
Table 48: Asia Pacific Market Value (US$ Mn), By End User , 2022 – 2032
Table 49: Asia Pacific Market , By Country, 2015 – 2021
Table 50: Asia Pacific Market , By Country, 2022 – 2032
Table 51: MEA Market Value (US$ Mn),By Solution , 2015 – 2021
Table 52: MEA Market Value (US$ Mn),By Solution , 2022 – 2032
Table 53: MEA Market Value (US$ Mn), By Technique , 2015 – 2021
Table 54: MEA Market Value (US$ Mn), By Technique , 2022 – 2032
Table 55: MEA Market Value (US$ Mn), By Organ Type , 2015 – 2021
Table 56: MEA Market Value (US$ Mn), By Organ Type , 2022 – 2032
Table 57: MEA Market Value (US$ Mn), By End User , 2015 – 2021
Table 58: MEA Market Value (US$ Mn), By End User , 2022 – 2032
Table 59: MEA Market , By Country, 2015 – 2021
Table 60: MEA Market , By Country, 2022 – 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Market Share, By Solution , 2022 & 2032
Figure 4: Global Market Y-o-Y Growth Projections, By Solution – 2022-2032
Figure 5: Global Market Attractiveness Index, By Solution – 2022-2032
Figure 6: Global Market Share, By Technique , 2022 & 2032
Figure 7: Global Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 8: Global Market Attractiveness Index, By Technique – 2022-2032
Figure 9: Global Market Share, By End User , 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 11: Global Market Attractiveness Index, By End User – 2022-2032
Figure 12: Global Market Share, By Organ Type , 2022 & 2032
Figure 13: Global Market Y-o-Y Growth Projections, By Organ Type – 2022-2032
Figure 14: Global Market Attractiveness Index, By Organ Type – 2022-2032
Figure 15: Global Market Share, By Region, 2022 & 2032
Figure 16: Global Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 17: Global Market Attractiveness Index, By Region – 2022-2032
Figure 18: North America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 19: North America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 20: North America Market Share, By Solution , 2022 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By Solution – 2022-2032
Figure 22: North America Market Attractiveness Index, By Solution – 2022-2032
Figure 23: North America Market Share, By Technique , 2022 & 2032
Figure 24: North America Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 25: North America Market Attractiveness Index, By Technique – 2022-2032
Figure 26: North America Market Share, By End User , 2022 & 2032
Figure 27: North America Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 28: North America Market Attractiveness Index, By End User – 2022-2032
Figure 29: North America Market Share, By Organ Type , 2022 & 2032
Figure 30: North America Market Y-o-Y Growth Projections, By Organ Type – 2022-2032
Figure 31: North America Market Attractiveness Index, By Organ Type – 2022-2032
Figure 32: North America Market Share, By Country, 2022 & 2032
Figure 33: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 34: North America Market Attractiveness Index, By Country – 2022-2032
Figure 35: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 36: Latin America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 37: Latin America Market Share, By Solution , 2022 & 2032
Figure 38: Latin America Market Y-o-Y Growth Projections, By Solution – 2022-2032
Figure 39: Latin America Market Attractiveness Index, By Solution – 2022-2032
Figure 40: Latin America Market Share, By Technique , 2022 & 2032
Figure 41: Latin America Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 42: Latin America Market Attractiveness Index, By Technique – 2022-2032
Figure 43: Latin America Market Share, By End User , 2022 & 2032
Figure 44: Latin America Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 45: Latin America Market Attractiveness Index, By End User – 2022-2032
Figure 46: Latin America Market Share, By Organ Type , 2022 & 2032
Figure 47: Latin America Market Y-o-Y Growth Projections, By Organ Type – 2022-2032
Figure 48: Latin America Market Attractiveness Index, By Organ Type – 2022-2032
Figure 49: Latin America Market Share, By Country, 2022 & 2032
Figure 50: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 51: Latin America Market Attractiveness Index, By Country – 2022-2032
Figure 52: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 53: Europe Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 54: Europe Market Share, By Solution , 2022 & 2032
Figure 55: Europe Market Y-o-Y Growth Projections, By Solution – 2022-2032
Figure 56: Europe Market Attractiveness Index, By Solution – 2022-2032
Figure 57: Europe Market Share, By Technique , 2022 & 2032
Figure 58: Europe Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 59: Europe Market Attractiveness Index, By Technique – 2022-2032
Figure 60: Europe Market Share, By End User , 2022 & 2032
Figure 61: Europe Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 62: Europe Market Attractiveness Index, By End User – 2022-2032
Figure 63: Europe Market Share, By Organ Type , 2022 & 2032
Figure 64: Europe Market Y-o-Y Growth Projections, By Organ Type – 2022-2032
Figure 65: Europe Market Attractiveness Index, By Organ Type – 2022-2032
Figure 66: Europe Market Share, By Country, 2022 & 2032
Figure 67: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 68: Europe Market Attractiveness Index, By Country – 2022-2032
Figure 69: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 70: MEA Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 71: MEA Market Share, By Solution , 2022 & 2032
Figure 72: MEA Market Y-o-Y Growth Projections, By Solution – 2022-2032
Figure 73: MEA Market Attractiveness Index, By Solution – 2022-2032
Figure 74: MEA Market Share, By Technique , 2022 & 2032
Figure 75: MEA Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 76: MEA Market Attractiveness Index, By Technique – 2022-2032
Figure 77: MEA Market Share, By End User , 2022 & 2032
Figure 78: MEA Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 79: MEA Market Attractiveness Index, By End User – 2022-2032
Figure 80: MEA Market Share, By Organ Type , 2022 & 2032
Figure 81: MEA Market Y-o-Y Growth Projections, By Organ Type – 2022-2032
Figure 82: MEA Market Attractiveness Index, By Organ Type – 2022-2032
Figure 83: MEA Market Share, By Country, 2022 & 2032
Figure 84: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 85: MEA Market Attractiveness Index, By Country – 2022-2032
Figure 86: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 87: Asia Pacific Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 88: Asia Pacific Market Share, By Solution , 2022 & 2032
Figure 89: Asia Pacific Market Y-o-Y Growth Projections, By Solution – 2022-2032
Figure 90: Asia Pacific Market Attractiveness Index, By Solution – 2022-2032
Figure 91: Asia Pacific Market Share, By Technique , 2022 & 2032
Figure 92: Asia Pacific Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 93: Asia Pacific Market Attractiveness Index, By Technique – 2022-2032
Figure 94: Asia Pacific Market Share, By End User , 2022 & 2032
Figure 95: Asia Pacific Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 96: Asia Pacific Market Attractiveness Index, By End User – 2022-2032
Figure 97: Asia Pacific Market Share, By Organ Type , 2022 & 2032
Figure 98: Asia Pacific Market Y-o-Y Growth Projections, By Organ Type – 2022-2032
Figure 99: Asia Pacific Market Attractiveness Index, By Organ Type – 2022-2032
Figure 100: Asia Pacific Market Share, By Country, 2022 & 2032
Figure 101: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 102: Asia Pacific Market Attractiveness Index, By Country – 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
